In the glittering world of celebrity-endorsed weight loss transformations and viral before-and-after photos, a darker narrative is emerging from the shadows ...
Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.
FreshSplash/Getty Images Researchers report that GLP-1 drugs ... Ozempic and Wegovy contain the active ingredient semaglutide. Ozempic has been approved for the treatment of type 2 diabetes ...
Hims & Hers Health is set to have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to ...
8don MSN
In response to complaints made publicly by the Partnership for Safe Medicine and the Obesity Society, Hims & Hers provided ...
Although the ad does not identify the medication, Hims & Hers offers compounded versions of the weight-loss drug semaglutide ... a trade group representing drug manufacturers, said the ad violates ...
Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Read more ...
Zacks.com on MSN12h
Hims & Hers Stock Jumps 156.9% in Three Months: What's Next?Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback